Company Filing History:
Years Active: 2000-2015
Title: Luc Schoonjans: Innovator in Stem Cell Research
Introduction
Luc Schoonjans is a notable inventor based in Wilsele, Belgium. He has made significant contributions to the field of stem cell research, holding three patents that focus on the derivation and culture of embryonic and adult stem cells. His work has implications for regenerative medicine and therapeutic applications.
Latest Patents
Schoonjans' latest patents include innovative methods for deriving pluripotent embryonic stem cells from mouse blastocysts and primordial germ cells. One of his inventions outlines a method for maintaining and growing these stem cells, utilizing a culture medium preconditioned by the rabbit fibroblast cell line Rab9. This medium contains less than 0.1 ng/ml of Leukemia Inhibitory Factor (LIF). Another patent encompasses compositions for deriving and maintaining both pluripotent and germ-line competent mammalian embryonic stem cells, as well as adult human stem cells and early progenitor cells. These compositions utilize a conditioned medium from a cell line that expresses limited amounts of LIF.
Career Highlights
Throughout his career, Luc Schoonjans has worked with various companies, including Thrombogenics NV and Thromb-X NV. His experience in these organizations has contributed to his expertise in stem cell research and development.
Collaborations
Schoonjans has collaborated with notable professionals in his field, including Randall Moreadith. These partnerships have enhanced his research and innovation efforts.
Conclusion
Luc Schoonjans is a prominent figure in the realm of stem cell research, with a focus on developing methods and compositions that advance the understanding and application of stem cells. His contributions are paving the way for future innovations in regenerative medicine.